On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Glycoselect Ltd's own share of each project, not the project's full budget.
- Horizon Europe€206k · 2 projects
- Horizon 2020€0 · 1 project
Projects
3 EU-funded projects, newest first. Each links to the official record.
- CanGoNanoAssociated partner
A training network on glyconanomaterials as precision tools to unveil key insights on the triggering of the antigen presenting cells against cancer
Horizon Europe · 2026–2030 · Project on CORDIS ↗
- IMProGlycoPartner
Inhibitor-Mediated Programming of Glycoforms
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€206ktheir share - synBIOcarbPartner
Synthetic biology of carbohydrate-binding proteins: engineering protein-carbohydrate interactions for diagnostics and cell targeting
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universitaet Fuer Bodenkultur WienAustria · 3 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 2 shared projects
- University of LeedsUnited Kingdom · 2 shared projects
- Engenes Biotech GmbHAustria · 2 shared projects
- Kobenhavns UniversitetDenmark · 1 shared project
- Danmarks Tekniske UniversitetDenmark · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- Stichting VuNetherlands · 1 shared project
- Stichting Amsterdam UmcNetherlands · 1 shared project
- Universita Degli Studi di MilanoItaly · 1 shared project
- Stichting Radboud Universitair Medisch CentrumNetherlands · 1 shared project
- Albert-Ludwigs-Universitaet FreiburgGermany · 1 shared project
- University of YorkUnited Kingdom · 1 shared project
- Technische Universitaet GrazAustria · 1 shared project
- Universidade Nova de LisboaPortugal · 1 shared project
- Universita Degli Studi di FirenzeItaly · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- bioeconomy
- biomolecules
- carbohydrates
- cell biology
- cells technologies
- immunotherapy
- nanotechnology
- neurobiology
- oncology
- proteins
- synthetic biology
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.